Although it has become clearer that survival and proliferation of breast cancer cells are relay upon active FAS-catalyzed de novo fatty acid synthesis, the relationship between breast cancer-associated FAS hyperactivity and the efficacy of chemotherapy has not been studied. This evidence concerns the gene FAS and breast carcinoma.